Publikationen, an denen er mitarbeitet Manuel García Cenoz (19)

2018

  1. Comparison of influenza vaccine effectiveness in preventing outpatient and inpatient influenza cases in older adults, northern spain, 2010/11 to 2015/16

    Eurosurveillance, Vol. 23, Núm. 2

  2. Interim 2017/18 influenza seasonal vaccine effectiveness: Combined results from five European studies

    Eurosurveillance, Vol. 23, Núm. 9

  3. Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18

    Eurosurveillance, Vol. 23, Núm. 7

2017

  1. Combined effectiveness of prior and current season influenza vaccination in northern Spain: 2016/17 mid-season analysis

    Eurosurveillance, Vol. 22, Núm. 7

2016

  1. Direct, indirect and total effects of 13-valent pneumococcal conjugate vaccination on invasive pneumococcal disease in children in Navarra, Spain, 2001 to 2014: Cohort and case–control study

    Eurosurveillance, Vol. 21, Núm. 14

  2. Effectiveness of subunit influenza vaccination in the 2014-2015 season and residual effect of split vaccination in previous seasons

    Vaccine, Vol. 34, Núm. 11, pp. 1350-1357

  3. Effects of previous episodes of influenza and vaccination in preventing laboratory-confirmed influenza in Navarre, Spain, 2013/14 season

    Eurosurveillance, Vol. 21, Núm. 22, pp. 1-10

2015

  1. Influenza vaccine effectiveness in preventing inpatient and outpatient cases in a season dominated by vaccine-matched influenza B virus

    Human Vaccines and Immunotherapeutics, Vol. 11, Núm. 7, pp. 1626-1633

2014

  1. Household transmission of influenza A(H1N1)pdm09 in the pandemic and post-pandemic seasons

    PLoS ONE, Vol. 9, Núm. 9

  2. Reduced incidence of invasive pneumococcal disease after introduction of the 13-valent conjugate vaccine in Navarre, Spain, 2001-2013

    Vaccine, Vol. 32, Núm. 22, pp. 2553-2562

2013

  1. Decline in influenza vaccine effectiveness with time after vaccination, Navarre, Spain, season 2011/12

    Eurosurveillance, Vol. 18, Núm. 5

  2. Early estimates of influenza vaccine effectiveness in Navarre, Spain: 2012/13 mid-season analysis

    Eurosurveillance, Vol. 18, Núm. 7

  3. Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010-2011: A population-based test-negative case-control study

    BMC Public Health, Vol. 13, Núm. 1

2011

  1. Diferencias entre las ondas gripales de veranoy de otoño durante lapandemiade gripe (H1N1) 2009 en Navarra

    Revista Espanola de Salud Publica, Vol. 85, Núm. 1, pp. 47-56

  2. Effectiveness of the monovalent influenza A(H1N1)2009 vaccine in Navarre, Spain, 2009-2010: Cohort and case-control study

    Vaccine, Vol. 29, Núm. 35, pp. 5919-5924

  3. Effectiveness of trivalent seasonal and monovalent influenza A(H1N1)2009 vaccines in population with major chronic conditions of Navarre, Spain: 2010/11 mid-season analysis

    Eurosurveillance, Vol. 16, Núm. 7

2009

  1. Effectiveness of Jeryl Lynn-containing vaccine in Spanish children

    Vaccine, Vol. 27, Núm. 15, pp. 2089-2093

  2. Effectiveness of teicoplanin versus vancomycin lock therapy in the treatment of port-related coagulase-negative staphylococci bacteraemia: a prospective case-series analysis

    International Journal of Antimicrobial Agents, Vol. 34, Núm. 5, pp. 482-485

  3. Rebrote de parotiditis en la era vacunal. Factores implicados en un brote en Navarra, 2006-2007

    Medicina Clinica, Vol. 133, Núm. 20, pp. 777-782